Welcome to Mundipharma
Right from the start, we are all about people and we are about patients.
The Mundipharma story, spanning over six decades, is one that brings together a visionary approach and a pioneering spirit – and is best told through our patients, our employees and the communities in which we serve. Our dedication to putting patients at the heart of every business decision has ensured that we continue to grow and more importantly, improve the lives of the people who need our medicines the most.
That foundation has not only delivered significant results, but is a reflection of our ability to convert entrepreneurism and innovation into business success.
We are focused on the transformation of Mundipharma’s business – by leveraging a shared spirit of innovation, we are building a growing presence in analgesia, respiratory, oncology, oncology supportive care and consumer healthcare. We constantly maintain high ethical standards, and best practice compliance, because we put patients first and they deserve nothing less. Our unique approach to partnerships has given us the opportunity to establish a strong market presence that covers the world’s pharmaceutical markets. Today we are an innovative organisation, with several thousand employees serving more than four billion patients and a distribution network covering six continents. And this is just the beginning of our story.
While we continue to grow and develop our business in all reaches of the globe, we also recognise that it is our people, innovation and our values that enable us to do what we do. We understand that we have a higher purpose – especially as the work we do has the ability to improve the quality of people’s lives everywhere.
Mundipharma will never lose sight of its heritage and history, and will retain its focus and core values. Because of that, we are confident about the future as we actively pursue innovative treatments and new opportunities in order to Bring More To Life.
About our CEO
Raman Singh oversees Mundipharma’s global operations in the US, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Under his leadership, Mundipharma has expanded from three to eight different therapy areas covering pharmaceuticals, over-the-counter medicines, and fast-moving consumer products. Its specialist areas include analgesia, biosimilars, oncology, oncology supportive care, ophthalmology, respiratory care and consumer healthcare. Raman has led Mundipharma through 26 consecutive quarters of growth resulting in annual sales of over $3B (USD). He is a Brand Ambassador for the Singapore Tourism Board, a Governor of the World Economic Forum Global Health and Healthcare Committee and part of the Advisory Board at Manchester City Football Club.